pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Elixsure DM
drug
save

dextromethorphan

Marketedupdated 3mo ago
by Moberg Pharma AB
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval8 co-mentions · 3 sources
  • drugPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE7 co-mentions · 2 sources
  • tagRecall6 co-mentions · 5 sources
  • drugguaifenesin6 co-mentions · 5 sources
  • drugguaifenesin ER6 co-mentions · 5 sources
  • drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN4 co-mentions · 1 sources
  • drugphenylephrine4 co-mentions · 1 sources
  • tagSmall Molecule4 co-mentions · 3 sources

all catalysts(0)

nothing on the calendar yet

Trials studying dextromethorphan

  • phase1A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participantsrecruitingn=42
  • phase2Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorderrecruitingn=30
  • phase3An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Studyterminatedn=139
  • phase2Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)terminatedn=181
  • phase1A Study of Imlunestrant (LY3484356) in Female Healthy Participantscompletedn=113
  • phase3A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitationcompletedn=456
  • phase1A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitisterminatedn=28
  • phase3A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorderrecruitingn=388
more trials →

News(1)

  • Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
    The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
    fiercebiotech · 8mo ago
brand
Elixsure DM
generic
dextromethorphan [INN]
indication
Cough
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?